Predicting the risk of nephrotoxicity in patients receiving colistimethate sodium: a multicentre, retrospective, cohort study: Table 1. | Zendy

Kady Phe | Zendy; Ryan K. Shields | Zendy; Frank Tverdek | Zendy; Samuel L Aitken | Zendy; David J. Guervil | Zendy; Wai-Ying M. Lam | Zendy; Rachel J. Musgrove | Zendy; Andrea M. Luce | Zendy; Vincent H. Tam | Zendy

Open Access

Predicting the risk of nephrotoxicity in patients receiving colistimethate sodium: a multicentre, retrospective, cohort study: Table 1.

Author(s) -

Kady Phe,

Ryan K. Shields,

Frank Tverdek,

Samuel L Aitken,

David J. Guervil,

Wai-Ying M. Lam,

Rachel J. Musgrove,

Andrea M. Luce,

Vincent H. Tam

Publication year - 2016

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkw329

Subject(s) - nephrotoxicity , medicine , retrospective cohort study , renal function , cohort , creatinine , rifle , cohort study , urology , toxicity , archaeology , history

With increasing rates of infections caused by MDR Gram-negative organisms, clinicians resort to older agents such as colistimethate sodium (CMS) despite a significant risk of nephrotoxicity. Several risk factors for CMS-associated nephrotoxicity have been reported, but they have yet to be validated. We compared the performance of published mathematical models in predicting the risk of CMS-associated nephrotoxicity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research